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This study introduces a refinement to a method for quantifying the sensitivity of multiple 
brain regions to a drug. Rapid quantitative pharmacodynamic imaging simultaneously 
estimates pharmacokinetic (PK) and pharmacodynamic (PD) parameters from a region 
of brain through administration of a drug during fMRI BOLD signal collection. Here we 
use the fact that the concentration of drug in arterial blood is essentially the same for all 
regions of the brain to more tightly estimate the time–concentration curve and hence 
reduce unwanted model flexibility in estimating PD parameters. Furthermore, assuming 
linear pharmacokinetics, we can appropriately combine responses to the drug across 
doses. To test this approach, a dopamine D1-like agonist, SKF38393, was administered 
intravenously to baboons (n = 4) during BOLD-sensitive fMRI. Each subject received 
four different doses of drug on four different occasions with order randomized. Data 
from the hypothalamus, midbrain, and striatum were used to estimate the most likely 
time–concentration curve; the 90% confidence interval for this curve was much tighter 
than the range of curves when data for each region and dose were considered one at a 
time. The most likely time–concentration curve was then used as prior information to 
constrain quantification of drug sensitivity (EC50) voxel-wise throughout the brain. The 
results support the use of rapid quantitative pharmacological imaging in determining 
appropriate and effective dosing for brain disorders such as Parkinson’s disease as well as 
for determining arterial drug concentration measurements when this data is not directly 
available.
